Can herbal granules protect kidneys in IgA disease?
NCT ID NCT07360002
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether Shenqi Yishen Granules, a traditional Chinese medicine, can reduce protein in the urine of adults with IgA nephropathy, a kidney disease. Researchers will compare the granules to a placebo in 102 participants over several months. The goal is to see if the treatment slows kidney damage and is safe.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Shenqi Yishen Granules (a traditional Chinese medicine compound)
- What this could lead to
- If it works, this could offer a new treatment option to reduce kidney damage in IgA nephropathy patients.
- What could go wrong
- This is an early-stage trial with only 102 participants, so results may not apply to everyone. The treatment is compared to a placebo, and its effectiveness is uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IGA NEPHROPATHY (IGAN) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Atacicept's Long-Term promise for kidney disease
- Scientists investigate mysterious loin pain in kidney disease
- New hope for kidney patients: drug aims to prevent relapse
- 800-Patient study aims to uncover best treatments for kidney disease
- New pill aims to tame kidney disease in Long-Term trial
- Could your gut and kidneys be affecting your brain? new MRI study investigates